as on February 7, 2026 at 7:59 am IST
Day's Low
Day's High
2.53%
Downside
0.74%
Upside
52 Week's Low
52 Week's High
91.63%
Downside
2.46%
Upside
Check Praxis Precision Medicines I market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$8.2B
EPS (TTM)
-13.1075
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-293.0M
Revenue (TTM)
7.5M
Profit Margin
0.00%
Return On Equity TTM
-75.20%
Compare market cap, revenue, PE, and other key metrics of Praxis Precision Medicines I with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $8.2B | -60.26% | NA | 0.00% | |
| BUY | $122.3B | 122.02% | 33.56 | 31.35% | |
| BUY | $47.7B | 98.75% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 57.42% | 18.28 | 32.13% |
The Praxis Precision Medicines I stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Praxis Precision Medicines I investment value today
Current value as on today
₹3,70,551
Returns
₹2,70,551
(+270.55%)
Returns from Praxis Precision Medicines I Stock
₹2,67,242 (+267.24%)
Dollar Returns*
₹3,309 (+3.31%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Praxis Precision Medicines I. Average target price of $570.38
Get share price movements and forecasts by analysts on Praxis Precision Medicines I.
What analysts predicted
44.06%UPSIDE
Target Price
$570.38
Current Price
$319.06
Analyzed by
12 Analysts
Target
$570.38
Praxis Precision Medicines I target price $570.38, a slight upside of 44.06% compared to current price of $319.06. According to 12 analysts rating.
Search interest for Praxis Precision Medicines I Stock has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 29 December
Mon, 06:07 PM
-Shares gained over 2% after BTIG named the stock a top pick for 2026 and raised its price target to $843.
Mon, 10:53 PM
-Praxis stock rose 14.24% after FDA granted Breakthrough Therapy Designation for ulixacaltamide for essential tremor.
Mon, 11:34 PM
-Shares gained 13% after BTIG raised price target to $843, indicating over 213% upside potential.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
![]()
In the last 3 years, PRAX has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
![]()
In the last 1 year, PRAX has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 6 months, PRAX stock has moved up by 595.6%
| Organisation | Praxis Precision Medicines I |
| Headquarters | 99 High Street, Boston, MA, United States, 02110 |
| Industry | Health Technology |
| CEO | Mr. Marcio Silva De'Souza M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Timothy Edwin Kelly | CFO & Treasurer |
Mr. Alex Nemiroff J.D. | General Counsel & Secretary |
Ms. Megan T. Sniecinski | Chief Operating Officer |
Ms. Kelly McCue | Chief People Officer |
Ms. Alyssa J. S. Wyant | Chief Regulatory & Quality Officer |
Mr. Marcio Silva De'Souza M.B.A. | President, CEO & Director |
Dr. Steven Petrou B.Sc. (Hons.), Ph.D. | Co-Founder and President of Research & Development |
Lauren Mastrocola | VP of Finance & Principal Accounting Officer |
Dr. Karl Hansen Ph.D. | Chief Technical Operations Officer |
Mr. Brian Spar | Chief of Staff |
Praxis Precision Medicines I share price today is $319.06 as on at the close of the market. Praxis Precision Medicines I share today touched a day high of $321.42 and a low of $310.99.
Praxis Precision Medicines I share touched a 52 week high of $326.91 on and a 52 week low of $26.7 on . Praxis Precision Medicines I stock price today i.e. is closed at $319.06,which is 2.40% down from its 52 week high and 1094.98% up from its 52 week low.
Praxis Precision Medicines I market capitalisation is $0.01T as on .
Indian investors can start investing in Praxis Precision Medicines I (PRAX) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Praxis Precision Medicines I stock (as per the Rupee-Dollar exchange rate as on ).
Based on Praxis Precision Medicines I share’s latest price of $319.06 as on February 7, 2026 at 2:29 am IST, you will get 0.0313 shares of Praxis Precision Medicines I. Learn more about
fractional shares .
Praxis Precision Medicines I stock has given -60.26% share price returns and 23.93% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?